Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,744
Closed -$251K 1815
2023
Q2
$251K Sell
2,744
-13,944
-84% -$1.14M 0.01% 1401
2023
Q1
$1.23M Sell
16,688
-9,564
-36% -$827K 0.05% 528
2022
Q4
$2.19M Buy
+26,252
New +$2.37M 0.12% 246
2022
Q3
Sell
-6,198
Closed -$652K 1545
2022
Q2
$652K Buy
+6,198
New +$792K 0.03% 735
2021
Q4
Sell
-21,391
Closed -$3.19M 1351
2021
Q3
$3.19M Buy
+21,391
New +$4.45M 0.23% 38
2020
Q4
Sell
-1,241
Closed -$293K 933
2020
Q3
$293K Buy
+1,241
New +$282K 0.06% 502

Other funds holding AMED

Jump Financial's AMED Position: Q3 2023 in Review

Jump Financial sold out of Amedisys (AMED) in Q3 2023, closing a stake of 2,744 shares — an estimated $251K sold.

Jump Financial first reported a position in AMED in Q3 2020 and held it in 6 quarters. The position peaked at $3.19M in Q3 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Jump Financial reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Jump Financial sold 2,744 Amedisys shares in Q3 2023, an estimated $251K.
  • Jump Financial first reported a position in Amedisys in Q3 2020 and held it in 6 quarters.
  • Jump Financial's Amedisys position peaked at $3.19M in Q3 2021.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Jump Financial's 13F filing for Q3 2023, filed 7 Nov 2023.